These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2021075

  • 1. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M, Slechtová J, Hůla J.
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [Abstract] [Full Text] [Related]

  • 2. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H, Shimazaki C, Nakanishi S, Hamami T, Nisio A, Isemura T, Katsume H, Nakagawa M, Ijichi H.
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [Abstract] [Full Text] [Related]

  • 3. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
    Hutchinson RJ, Bailey C, Wood D, Donaldson MH.
    Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866
    [Abstract] [Full Text] [Related]

  • 4. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
    Tsubaki K, Horiuchi A, Kitani T, Taniguchi N, Masaoka T, Shibata H, Yonezawa T, Tsubakio T, Kawagoe H, Shinohara Y.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1420-7. PubMed ID: 6742867
    [Abstract] [Full Text] [Related]

  • 5. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
    Gulen H, Kazanci E, Mese T, Uzunkaya D, Erbay A, Tavli V, Vergin C.
    Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
    [Abstract] [Full Text] [Related]

  • 6. [Chronic cardiotoxicity of anthracycline derivatives and possible prevention by coenzyme Q10].
    Tajima M.
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1211-6. PubMed ID: 6471423
    [Abstract] [Full Text] [Related]

  • 7. [Cardiotoxicity of mitoxantrone].
    Okuma K, Ariyoshi Y, Ota K.
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3040-5. PubMed ID: 3464231
    [Abstract] [Full Text] [Related]

  • 8. [Cardiotoxic effect of anthracycline antibiotics].
    Jovanović I, Ceranić LJ, Simeunović S, Cvetković P.
    Bilt Hematol Transfuz; 1983 Oct; 11(2-3):51-7. PubMed ID: 6680300
    [Abstract] [Full Text] [Related]

  • 9. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
    Trouet A, Sokal G.
    Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556
    [Abstract] [Full Text] [Related]

  • 10. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K, Furuta I, Ota K.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [Abstract] [Full Text] [Related]

  • 11. [Cardiotoxicity of cytostatics in long-term therapy].
    Bühner R.
    Dtsch Med Wochenschr; 1978 Aug 18; 103(33):1311-2. PubMed ID: 98313
    [No Abstract] [Full Text] [Related]

  • 12. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography.
    Galli MA, Conter V, Zanetto F, Jankovic M, Ferrari L, Baio G, Masera G.
    Haematologica; 1987 Aug 18; 72(4):347-50. PubMed ID: 3117636
    [No Abstract] [Full Text] [Related]

  • 13. Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
    Adamson RH.
    Cancer Chemother Rep; 1974 Aug 18; 58(3):293-4. PubMed ID: 4841712
    [No Abstract] [Full Text] [Related]

  • 14. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group.
    Steinherz LJ, Graham T, Hurwitz R, Sondheimer HM, Schwartz RG, Shaffer EM, Sandor G, Benson L, Williams R.
    Pediatrics; 1992 May 18; 89(5 Pt 1):942-9. PubMed ID: 1579408
    [Abstract] [Full Text] [Related]

  • 15. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV.
    Semin Oncol; 2006 Jun 18; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [Abstract] [Full Text] [Related]

  • 16. [Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion].
    Orditura M, De Vita F, Ciaramella F, Catalano G.
    Ann Ital Med Int; 1994 Jun 18; 9(4):243-8. PubMed ID: 7893575
    [Abstract] [Full Text] [Related]

  • 17. Anthracycline-induced cardiotoxicity in adult hematologic malignancies.
    Johnson SA.
    Semin Oncol; 2006 Jun 18; 33(3 Suppl 8):S22-7. PubMed ID: 16781286
    [Abstract] [Full Text] [Related]

  • 18. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE.
    Semin Oncol; 2006 Jun 18; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The effect of the anthracycline derivative doxorubicin on myocardial function in children].
    Sobotka-Plojhar MA, Daniëls O, Rohmer J, Veerman AJ, Lippens R, van Lier H.
    Ned Tijdschr Geneeskd; 1989 Jul 08; 133(27):1367-70. PubMed ID: 2797225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.